Bristol Myers Squibb
Bristol Myers Squibb is in pahse 1 of research to develop SARS-CoV-2 mAb Duo for COVID-19 therapy or prevention
Rankings by
Национальный рейтинг91st
in United States Региональный рейтинг99th
in North America and Caribbean Глобальный рейтинг251st
worldwide